(Q37470939)

20 August 2017

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure (English)

1 reference

20 August 2017

chronic myeloid leukemia

0 references

1 reference

1 reference

Francesca Palandri

1

0 references

Simona Soverini

object named as

Simona Soverini

series ordinal

3

0 references

Gianantonio Rosti

series ordinal

9

object named as

Gianantonio Rosti

1 reference

20 August 2017

2

Fausto Castagnetti

1 reference

20 August 2017

8

Giovanni Martinelli

1 reference

20 August 2017

5

Gabriele Gugliotta

1 reference

20 August 2017

10

Michele Baccarani

1 reference

20 August 2017

6

Simona Luatti

1 reference

20 August 2017

4

Angela Poerio

1 reference

20 August 2017

7

Marilina Amabile

1 reference

20 August 2017

16 July 2009

1 reference

20 August 2017

1 reference

20 August 2017

94

1 reference

20 August 2017

12

1 reference

20 August 2017

1758-1761

1 reference

Tasigna for chronic and accelerated phase Philadelphia chromosome--positive chronic myelogenous leukemia resistant to or intolerant of imatinib

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Pancreatitis after endoscopic retrograde cholangio-pancreatography

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Benign pancreatic hyperenzymemia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

The regulation of exocytosis in the pancreatic acinar cell

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Cycling, stressed-out and nervous: cellular functions of c-Abl

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Where does serum amylase come from and where does it go?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Early changes in pancreatic acinar cell calcium signaling after pancreatic duct obstruction

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2791949

Direct pancreatic function test (duodenal intubation) in the diagnosis of chronic pancreatitis

2 September 2018

1 reference

12 December 2020

The prognostic significance of moderate hyperamylasemia in the evaluation of the emergency department patient

1 reference

12 December 2020

Is hyperamylasemia related to dyslipidemia?

1 reference

12 December 2020

Pancreatic hyperenzymemia: clinical significance and diagnostic approach

1 reference

12 December 2020

Bcr-Abl resistance screening predicts a limited spectrum of point mutations to be associated with clinical resistance to the Abl kinase inhibitor nilotinib (AMN107)

1 reference

12 December 2020

10.3324/HAEMATOL.2009.010496

Identifiers

DOI

1 reference

20 August 2017

1 reference

PMC publication ID

2791949

20 August 2017

PubMed publication ID

19608673

1 reference

PMC publication ID

2791949